Analysis of white fat demonstrated a significant reduction in the size of fat cells in the secretome-treated PCOS group compared with the untreated PCOS group (Fig S8a), and the expression of UCP1 in brown fat tissue was also significantly higher in the secretome-treated PCOS group compared with untreated PCOS group (Fig S8b). Here, UCP1 is linked to polycystic ovary syndrome.